Proceedings: Epidermolytic hyperkeratosis.
D002981:Clindamycin / Q000627:therapeutic use; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007642:Keratosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011409:Propylene Glycols / Q000627:therapeutic use
D011409:Propylene Glycols; D002981:Clindamycin